Evidence map›Paper›PMID 40524934›Full record

ArticleERJ open research2025

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly.

Vasile Foris, Aleksandar Bokan, Katarina Zeder, Alessandra Cuomo, Olivier Sitbon, Anton Vonk Noordegraaf, Mona Lichtblau, Athénaïs Boucly

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vasile ForisChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0002-8863-0298
Aleksandar BokanDepartment of Pneumonology and Intensive Care Medicine, SLK Clinics, Loewenstein, Germany.ORCID https://orcid.org/0000-0003-0549-3919
Katarina ZederDivision of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0002-8415-727X
Alessandra CuomoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Olivier SitbonUniversité Paris-Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-1942-1951
Anton Vonk NoordegraafDepartment of Pulmonary Medicine, Amsterdam UMC, Amsterdam Cardiovascular Sciences Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-4057-758X
Mona LichtblauDepartment of Pulmonology, University Hospital Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0003-4485-1758
Athénaïs BouclyUniversité Paris-Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0001-6246-5557

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40524934
PMCPMC12168176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.